Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries.There have been rapid developments of therapies that today can halt or even reverse aspects of vision loss resulting from AMD among those most severely affected, and there is promise of future therapies that may prevent vision loss. This book provides an overview about AMD; an update on the current understanding of AMD, pathophysiology, the use of diagnostic tests, the management of both non-neovascular and neovascular AMD as well as future directions in treatment and its limitations. It also looks into the future with potential treatment options that are now under investigation in clinical trials.

Age factors in disease. --- Macular degeneration. --- Dystrophy, Retinal --- Macular degeneration --- Retina --- Retinal dystrophy --- Degeneration (Pathology) --- Age and disease --- Diseases --- Aging --- Degeneration --- Age factors --- Pathology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book focuses on the current approaches in the medical and surgical treatment of the most diffuse and important ocular diseases. It reports the latest developments in surgery (anterior segment surgery, posterior pole surgery, etc.) for various types of ocular disease, including glaucoma, corneal diseases, and vitreoretinal disease. the latest developments in the surgical field of ocular disease from the anterior segment to the posterior pole going through the main ocular disease (cataract surgery in normal and/or complicated conditions, glaucoma, corneal diseases, and vitreoretinal disease), with the latest developments in the treatment of ocular disease that enable improved surgical outcomes and fewer complications.

Ophthalmology.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The emergence of H5N1 avian influenza in 1997 and of the influenza A H1N1 of swine origin in 2009 calls for new, rapid and sustainable solutions for both seasonal and pandemic influenza viruses. During the last ten years, science and technology have made enormous progress, and we are now able to monitor in real time the genetics of viruses while they spread globally, to make more powerful vaccines using novel adjuvants, and to generate viruses in the laboratory using reverse genetics. This volume not only provides state-of-the-art information on the biology of influenza viruses and on influenza vaccines, but is also designed to be a resource to face the present H1N1 pandemic and to plan for long-term global and sustainable solutions.

Influenza A virus -- Immunology. --- Influenza B virus -- Immunology. --- Influenza Vaccines -- Therapeutic use. --- Influenza vaccines. --- Influenza viruses. --- Influenza, Human. --- Influenza vaccines --- Influenza --- Influenza viruses --- Orthomyxoviridae Infections --- Influenza A virus --- Respiratory Tract Infections --- Viral Vaccines --- Respiratory Tract Diseases --- Vaccines --- RNA Virus Infections --- Influenzavirus A --- Influenza A Virus, H1N1 Subtype --- Influenza Vaccines --- Influenza, Human --- Orthomyxoviridae --- Virus Diseases --- Diseases --- Biological Products --- RNA Viruses --- Complex Mixtures --- Chemicals and Drugs --- Vertebrate Viruses --- Viruses --- Organisms --- Biology --- Health & Biological Sciences --- Microbiology & Immunology --- Influenza. --- Flu --- Flu, Respiratory --- Grippe --- Respiratory flu --- Influenza virus vaccines --- Medicine. --- Virology. --- Life sciences. --- Biomedicine. --- Life Sciences, general. --- Orthomyxoviruses --- Respiratory infections --- Virus diseases --- Viral vaccines --- Medical virology. --- Biosciences --- Sciences, Life --- Science --- Medical microbiology --- Virology --- Microbiology